About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
News
NOTICE
NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF BOSNALIJEK D.D.
In accordance with the provisions of Article 45 (3), Article 46 (2) (3) and (5), Article 47 and Article 48 (1) of the current Statute of Bosnalijek d.d. (consolidated text, no. 2830/2017 of 18.09.2017), Article 230 (1) and Article 232 (3) of the Law on Companies (Official Gazette of FBiH, no. 81/15 and 75/2) and pursuant to the Supervisory Board Decision no. 3/22 of 06.01.2022, the following is hereby published:
MORE
NOTICE
NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF BOSNALIJEK D.D.
In accordance with the provisions of Article 45 (3), Article 46 (2) (3) and (5), Article 47 and Article 48 (1) of the current Statute of Bosnalijek d.d. (consolidated text, no. 2830/2017 of 18.09.2017), Article 230 (1) and Article 232 (3) of the Law on Companies (Official Gazette of FBiH, no. 81/15 and 75/2) and pursuant to the Supervisory Board Decision no. 3/22 of 06.01.2022, the following is hereby published:
Read more
NOTICE
Notice on reconvening of regular annual shareholders’ Assembly of Bosnalijek JSC
In accordance with Article 55 Paragraph (2) and (3) of applicable Articles of Association of Bosnalijek JSC and Article 233 Paragraph (2), (3) and (4) of Law on Companies (Official Gazette of FB&H, No. 81/15), based on the Decision to Reconvene regular annual Shareholders’ Assembly No: 2450/20 of 22 June 2020., the Supervisory Board announces...
Read more
Previous news
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
REPORT BY VOTING COMMITTEE
Notice of convening annual regular assembly of Bosnalijek d.d.
Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pha ...
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race ...
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
Professional Lecture for Doctors and Patients Held On the Occasion of th ...
Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ...
Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ...
The Third Congress of Pharmacists from Montenegro held in Bečići
Foreign markets recognize the quality of our products
Bosnalijek won the prestigious industry award
Bosnalijek is again the best employer in the pharmaceutical sector in 20 ...
Successful Two-Day Roundtable of Psychiatrists Held
“Global Enterofuryl® Speaker Training – GEST” conference gathers nationa ...
4th “Acute Coronary Syndrome” training for 60 young doctors
A successful year for Bosnalijek, revenue up by 10 percent
Third Generation of American Yale University Students Visits Bosnalijek
Notice of convening annual regular assembly of Bosnalijek joint stock co ...
Bosnalijek for the 21st Century